Clinical trial
The Effectiveness of Lower Cyclosporine Doses for Psoriasis
NCT00377325 · University of Rochester, Other · Withdrawn
Key facts
| NCT number | NCT00377325 |
|---|---|
| Title | The Effectiveness of Lower Cyclosporine Doses for Psoriasis |
| Official title | Cyclosporine in the Pharmacotherapy of Psoriasis |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Cyclosporine |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Sep 18, 2006 |
| Last update posted | Nov 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: